SCHEMBL5546

SCHEMBL5546

COC[C@]1(O)CC[C@]2(CCN(c3ccc(OC(C)C)cc3)C2)CC1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LIPE Q05469 4/20 0.44
FFAR4 Q5NUL3 3/20 0.39
CYP3A4 P08684 10/20 0.38
CYP2C19 P33261 5/20 0.38
TSHR P16473 2/20 0.38
ALDH1A1 P00352 6/20 0.38
USP2 O75604 5/20 0.38
CYP2C9 P11712 5/20 0.38
HSD17B10 Q99714 4/20 0.38
CYP1A2 P05177 4/20 0.38
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 2/20 0.38
MAPT P10636 2/20 0.38
HIF1A Q16665 3/20 0.38
MAPK1 P28482 2/20 0.38
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5611 0.85 CYP3A4 (0.40) CYP3A4CYP2C19TSHRALDH1A1USP2
SCHEMBL5569 0.83 USP2 (0.41) LIPEFFAR4CYP3A4CYP2C19TSHR
SCHEMBL5655 0.81 CYP3A4 (0.40) CYP3A4CYP2C19TSHRALDH1A1USP2
SCHEMBL5989 0.81 CYP3A4 (0.40) CYP3A4CYP2C19TSHRALDH1A1USP2
SCHEMBL5381 0.80 CYP3A4 (0.39) CYP3A4CYP2C19TSHRALDH1A1USP2
SCHEMBL6125 0.78 FFAR4 (0.41) LIPEFFAR4CYP3A4CYP2C19TSHR
SCHEMBL5391 0.75 CYP3A4 (0.35) CYP3A4CYP2C19TSHRALDH1A1USP2
SCHEMBL5081 0.75 SIGMAR1 (0.41) LIPEFFAR4CYP3A4CYP2C19TSHR
SCHEMBL1589755 0.74 LIPE (0.76) LIPE
SCHEMBL1589752 0.74 LIPE (0.76) LIPE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed